GlassScriptPhysician profile
Charles D Atnip
NPI 1245343003
$1,791.67
in general payments reported to CMS, 2019-2025
20 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $100 · 2021: $202 · 2022: $406 · 2023: $281 · 2024: $208 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $514.66 | 2019-2025 | Clareon, Hydrus Microstent, Tryptyr |
| Abbvie INC. | $212.42 | 2023-2025 | Lumigan, Alphagan P |
| Oyster Point Pharma, INC. | $157.66 | 2023-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $127.31 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $124.13 | 2020-2025 | |
| Bausch & Lomb Americas INC. | $102.04 | 2022-2023 | Vyzulta, Miebo |
| Mallinckrodt Hospital Products INC. | $100.34 | 2022-2023 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $95.01 | 2019-2022 | |
| Allergan, INC. | $69.68 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $60.13 | 2019-2021 | |
| Ocular Therapeutix, INC. | $48.46 | 2022-2023 | Dextenza |
| Tarsus Pharmaceuticals, INC. | $45.14 | 2025 | Xdemvy |
| Carl Zeiss Meditec USA, INC. | $27.09 | 2023 | Lumera 700 |
| Boston Scientific Corporation | $23.60 | 2025 | Enroute Transcarotid Stent |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.84 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14.98 | 2024 | Arcpoint |
| Rayner Intraocular Lenses Limited | $14.16 | 2023 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Kowa Pharmaceuticals America, INC. | $13.97 | 2023 | Seglentis |
| Shire North American Group INC | $12.40 | 2019 | |
| Omeros Corporation | $11.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Atnip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.